Selected research
Industry Research
Implantable Drug Eluting Balloon Industry Research Report 2026
Market perspective
The global Implantable Drug Eluting Balloon market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Implantable Drug Eluting Balloon is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Implantable Drug Eluting Balloon is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Implantable Drug Eluting Balloon is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Implantable Drug Eluting Balloon include Yinyi Biotech, Medtronic, Philips, Boston Scientific, B. Braun, Eurocor, BD, Aachen Resonance and Biotronic, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Implantable Drug Eluting Balloon market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Implantable Drug Eluting Balloon Market by Company
Yinyi Biotech
Medtronic
Philips
Boston Scientific
B. Braun
Eurocor
BD
Aachen Resonance
Biotronic
Implantable Drug Eluting Balloon Segment by Type
Peripheral DEBs
Coronary DEBs
Implantable Drug Eluting Balloon Segment by Application
Catheterization Laboratory
Hospital
Other
Implantable Drug Eluting Balloon Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Implantable Drug Eluting Balloon market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Implantable Drug Eluting Balloon and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Implantable Drug Eluting Balloon.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Implantable Drug Eluting Balloon manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Implantable Drug Eluting Balloon by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Implantable Drug Eluting Balloon in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Peripheral DEBs
- Coronary DEBs
Applications
- Catheterization Laboratory
- Hospital
- Other
Companies covered
- Yinyi Biotech
- Medtronic
- Philips
- Boston Scientific
- B. Braun
- Eurocor
- BD
- Aachen Resonance
- Biotronic
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Implantable Drug Eluting Balloon Market Size (2021-2032)
- 2.2.2 Global Implantable Drug Eluting Balloon Sales (2021-2032)
- 2.2.3 Global Implantable Drug Eluting Balloon Market Average Price (2021-2032)
- 2.3 Implantable Drug Eluting Balloon by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Peripheral DEBs
- 2.3.3 Coronary DEBs
- 2.4 Implantable Drug Eluting Balloon by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Catheterization Laboratory
- 2.4.3 Hospital
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Implantable Drug Eluting Balloon Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Implantable Drug Eluting Balloon Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Implantable Drug Eluting Balloon Revenue of Manufacturers (2021-2026)
- 3.4 Global Implantable Drug Eluting Balloon Average Price by Manufacturers (2021-2026)
- 3.5 Global Implantable Drug Eluting Balloon Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Implantable Drug Eluting Balloon, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Implantable Drug Eluting Balloon, Product Type & Application
- 3.8 Global Manufacturers of Implantable Drug Eluting Balloon, Established Date
- 3.9 Global Implantable Drug Eluting Balloon Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Yinyi Biotech
- 4.1.1 Yinyi Biotech Company Information
- 4.1.2 Yinyi Biotech Business Overview
- 4.1.3 Yinyi Biotech Implantable Drug Eluting Balloon Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Yinyi Biotech Implantable Drug Eluting Balloon Product Portfolio
- 4.1.5 Yinyi Biotech Recent Developments
- 4.2 Medtronic
- 4.2.1 Medtronic Company Information
- 4.2.2 Medtronic Business Overview
- 4.2.3 Medtronic Implantable Drug Eluting Balloon Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Medtronic Implantable Drug Eluting Balloon Product Portfolio
- 4.2.5 Medtronic Recent Developments
- 4.3 Philips
- 4.3.1 Philips Company Information
- 4.3.2 Philips Business Overview
- 4.3.3 Philips Implantable Drug Eluting Balloon Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Philips Implantable Drug Eluting Balloon Product Portfolio
- 4.3.5 Philips Recent Developments
- 4.4 Boston Scientific
- 4.4.1 Boston Scientific Company Information
- 4.4.2 Boston Scientific Business Overview
- 4.4.3 Boston Scientific Implantable Drug Eluting Balloon Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Boston Scientific Implantable Drug Eluting Balloon Product Portfolio
- 4.4.5 Boston Scientific Recent Developments
- 4.5 B. Braun
- 4.5.1 B. Braun Company Information
- 4.5.2 B. Braun Business Overview
- 4.5.3 B. Braun Implantable Drug Eluting Balloon Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 B. Braun Implantable Drug Eluting Balloon Product Portfolio
- 4.5.5 B. Braun Recent Developments
- 4.6 Eurocor
- 4.6.1 Eurocor Company Information
- 4.6.2 Eurocor Business Overview
- 4.6.3 Eurocor Implantable Drug Eluting Balloon Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Eurocor Implantable Drug Eluting Balloon Product Portfolio
- 4.6.5 Eurocor Recent Developments
- 4.7 BD
- 4.7.1 BD Company Information
- 4.7.2 BD Business Overview
- 4.7.3 BD Implantable Drug Eluting Balloon Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 BD Implantable Drug Eluting Balloon Product Portfolio
- 4.7.5 BD Recent Developments
- 4.8 Aachen Resonance
- 4.8.1 Aachen Resonance Company Information
- 4.8.2 Aachen Resonance Business Overview
- 4.8.3 Aachen Resonance Implantable Drug Eluting Balloon Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Aachen Resonance Implantable Drug Eluting Balloon Product Portfolio
- 4.8.5 Aachen Resonance Recent Developments
- 4.9 Biotronic
- 4.9.1 Biotronic Company Information
- 4.9.2 Biotronic Business Overview
- 4.9.3 Biotronic Implantable Drug Eluting Balloon Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Biotronic Implantable Drug Eluting Balloon Product Portfolio
- 4.9.5 Biotronic Recent Developments
5 Global Implantable Drug Eluting Balloon Market Scenario by Region
- 5.1 Global Implantable Drug Eluting Balloon Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Implantable Drug Eluting Balloon Sales by Region: 2021-2032
- 5.2.1 Global Implantable Drug Eluting Balloon Sales by Region: 2021-2026
- 5.2.2 Global Implantable Drug Eluting Balloon Sales by Region: 2027-2032
- 5.3 Global Implantable Drug Eluting Balloon Revenue by Region: 2021-2032
- 5.3.1 Global Implantable Drug Eluting Balloon Revenue by Region: 2021-2026
- 5.3.2 Global Implantable Drug Eluting Balloon Revenue by Region: 2027-2032
- 5.4 North America Implantable Drug Eluting Balloon Market Facts & Figures by Country
- 5.4.1 North America Implantable Drug Eluting Balloon Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Implantable Drug Eluting Balloon Sales by Country (2021-2032)
- 5.4.3 North America Implantable Drug Eluting Balloon Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Implantable Drug Eluting Balloon Market Facts & Figures by Country
- 5.5.1 Europe Implantable Drug Eluting Balloon Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Implantable Drug Eluting Balloon Sales by Country (2021-2032)
- 5.5.3 Europe Implantable Drug Eluting Balloon Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Implantable Drug Eluting Balloon Market Facts & Figures by Country
- 5.6.1 Asia Pacific Implantable Drug Eluting Balloon Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Implantable Drug Eluting Balloon Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Implantable Drug Eluting Balloon Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Implantable Drug Eluting Balloon Market Facts & Figures by Country
- 5.7.1 South America Implantable Drug Eluting Balloon Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Implantable Drug Eluting Balloon Sales by Country (2021-2032)
- 5.7.3 South America Implantable Drug Eluting Balloon Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Implantable Drug Eluting Balloon Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Implantable Drug Eluting Balloon Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Implantable Drug Eluting Balloon Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Implantable Drug Eluting Balloon Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Implantable Drug Eluting Balloon Sales by Type (2021-2032)
- 6.1.1 Global Implantable Drug Eluting Balloon Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Implantable Drug Eluting Balloon Sales Market Share by Type (2021-2032)
- 6.2 Global Implantable Drug Eluting Balloon Revenue by Type (2021-2032)
- 6.2.1 Global Implantable Drug Eluting Balloon Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Implantable Drug Eluting Balloon Revenue Market Share by Type (2021-2032)
- 6.3 Global Implantable Drug Eluting Balloon Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Implantable Drug Eluting Balloon Sales by Application (2021-2032)
- 7.1.1 Global Implantable Drug Eluting Balloon Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Implantable Drug Eluting Balloon Sales Market Share by Application (2021-2032)
- 7.2 Global Implantable Drug Eluting Balloon Revenue by Application (2021-2032)
- 7.2.1 Global Implantable Drug Eluting Balloon Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Implantable Drug Eluting Balloon Revenue Market Share by Application (2021-2032)
- 7.3 Global Implantable Drug Eluting Balloon Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Implantable Drug Eluting Balloon Value Chain Analysis
- 8.1.1 Implantable Drug Eluting Balloon Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Implantable Drug Eluting Balloon Production Mode & Process
- 8.2 Implantable Drug Eluting Balloon Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Implantable Drug Eluting Balloon Distributors
- 8.2.3 Implantable Drug Eluting Balloon Customers
9 Global Implantable Drug Eluting Balloon Analyzing Market Dynamics
- 9.1 Implantable Drug Eluting Balloon Industry Trends
- 9.2 Implantable Drug Eluting Balloon Industry Drivers
- 9.3 Implantable Drug Eluting Balloon Industry Opportunities and Challenges
- 9.4 Implantable Drug Eluting Balloon Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst